Moderna, Inc. cotiza a 213.74 USD y tiene una capitalización bursátil de $85.3B. En los últimos 12 meses ha facturado $2.2B con un margen de flujo de caja libre del -106.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epst…
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.97 | $-3.40 | $-2.11 |
| Estimado | $-1.27 | $-2.06 | $-3.88 | $-2.64 |
| Sorpresa | — | +4.4% | +12.4% | +20.1% |
| Métrica | MRNA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 55.4% | 57.0% | -1.7% |
| Operating Margin | -158.1% | -38.6% | -119.5% |
| Net Margin | -145.2% | -33.6% | -111.6% |
| FCF Margin | -106.2% | -13.9% | -92.4% |
| ROE | -32.6% | -40.4% | +7.8% |
| ROA | -22.9% | -32.0% | +9.1% |
| Current Ratio | 3.29 | 2.84 | +0.45 |
| Debt / Equity | 0.07 | 0.28 | -0.21 |